Eliciting Depression Patients’ Preferences for Medication Management: A Protocol for Discrete Choice Experiment

References

• Zald D, McHugo M, Ray K, Glahn D, Eickhoff S, Laird A. Meta-analytic connectivity modeling reveals differential functional connectivity of the medial and lateral orbitofrontal cortex. Cereb Cortex. 2014;24(1):232–248. doi:10.1093/cercor/bhs308
   PubMed Web of Science ®Google Scholar
• Huang Y, Wang Y, Wang H, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211–224. doi:10.1016/S2215-0366(18)30511-X
   PubMed Web of Science ®Google Scholar
• Roca M, Vives M, López-Navarro E, García-Campayo J, Gili M. Cognitive impairments and depression: a critical review. Actas espanolas de psiquiatria. 2015;43(5):187–193.
   PubMed Web of Science ®Google Scholar
• Rock P, Roiser L, Riedel WJ, et al. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med London. 2014;44(10):2029–2040. doi:10.1017/S0033291713002535
   PubMed Web of Science ®Google Scholar
• Liu B, Qin P, Liu Y, Yuan L, Gu L, Jia C. Mental disorders and suicide attempt in rural China. Psychiatry Res. 2018;261:190–196. doi:10.1016/j.psychres.2017.12.087
   PubMed Web of Science ®Google Scholar
• Whiteford H, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet Oncol. 2013;382(9904):1575–1586. doi:10.1016/S0140-6736(13)61611-6
   Google Scholar
• Graaf RD, Tuithof M, Dorsselaer SV, Have MT. Verzuim door psychische en somatische aandoeningen bij werkenden. Resultaten van de ‘Netherlands Mental Health Survey and Incidence Study-2’ (NEMESIS-2) [Absenteeism due to psychological or somatic disorders in workers. Results of the ‘Netherlands Mental H. Utrecht: Trimbos-Instituut; 2011.
   Google Scholar
• Kazdin AE. Novel models for delivering mental health services and reducing the burdens of mental illness. Clin Psychol Sci. 2013;1(2):170–191. doi:10.1177/2167702612463566
   Google Scholar
• World Bank Group and W. Out of the shadows: making mental health a global development priority organized by World Bank Group&WHO; 2016. Available from: http://www.worldbank.org/en/events/2016/03/09/out-of-the-shadows-making-mental-health-A-global-priority. Accessed April 13, 2014.
   Google Scholar
• Chisholm D, Sweeny K, Sheehan P, et al. Scaling-up treatment of depression and anxiety: a global return on investment analysis. Lancet Psychiatry. 2016;3(5):415–424. doi:10.1016/S2215-0366(16)30024-4
   PubMed Web of Science ®Google Scholar
• Alonso J, Petukhova M, Vilagut G, et al. Days out of role due to common physical and mental conditions: results from the WHO World Mental Health surveys. Mol Psychiatry. 2011;16(12):1234–1246. doi:10.1038/mp.2010.101
   PubMed Web of Science ®Google Scholar
• Cardoso G, Xavier M, Vilagut G, et al. Days out of role due to common physical and mental conditions in Portugal: results from the WHO World Mental Health Survey. BJPsych Open. 2017;3(1):15–21. doi:10.1192/bjpo.bp.115.002402
   PubMed Web of Science ®Google Scholar
• Bruffaerts R, Vilagut G, Demyttenaere K, et al. Role of common mental and physical disorders in partial disability around the world. Br J Psychiatry. 2012;200(6):454–461. doi:10.1192/bjp.bp.111.097519
   PubMed Web of Science ®Google Scholar
• Ya-juan N. Interpretation of drug therapy of Chinese Guidelines for Prevention and Treatment of Depression. ClinMed J. 2018;16(5):6–8.
   Google Scholar
• Bosworth H, Voils C, Potter G, Steffens D. The effects of antidepressant medication adherence as well as psychosocial and clinical factors on depression outcome among older adults. Inte j Geriatric Psychiatry. 2008;23(2):129–134. doi:10.1002/gps.1852
   PubMed Web of Science ®Google Scholar
• Sriharsha M, Treatment PA. Disease Related Factors Affecting Non-adherence among Patients on Long Term Therapy of Antidepressants. J Depression Anxiety. 2015;04:02. doi:10.4172/2167-1044.1000175
   Google Scholar
• Liu X, Tepper P, Able S. Adherence and persistence with duloxetine and hospital utilization in patients with major depressive disorder. Int Clin Psychopharmacol. 2011;26(3):173–180. doi:10.1097/YIC.0b013e328343ba1e
   PubMed Web of Science ®Google Scholar
• Ho S, Chong H, Chaiyakunapruk N, Tangiisuran B, Jacob S. Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: a systematic review. J Affective Disorders. 2016;193:1–10. doi:10.1016/j.jad.2015.12.029
   PubMed Web of Science ®Google Scholar
• Alekhya P, Sriharsha M, Ramudu RV, Shivanandh B, Reddy YH. Adherence to antidepressant therapy: sociodemographic factor wise distribution. Int J Pharm Clin Res. 2015;7(3):180–184.
   Google Scholar
• Banerjee S, Varma RP. Factors Affecting Non-Adherence among Patients Diagnosed with Unipolar Depression in a Psychiatric Department of a Tertiary Hospital in Kolkata, India. Depress Res Treat. 2013;2013:809542. doi:10.1155/2013/809542
   PubMedGoogle Scholar
• Jin-liang W, Chen-chen Y, Qi Y, Ping F, Yang X. Influencing factors of antidepressant polypharmacy in inpatients with depression. Chin J Hospital Pharm. 2019;39(20):2081–2085.
   Google Scholar
• Whiteford HA, Degenhardt L, Rehm J. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575–1586.
   PubMed Web of Science ®Google Scholar
• Swift JK, Callahan JL, Vollmer BM. Preferences. J Clin Psychol. 2011;67(2):155–165. doi:10.1002/jclp.20759
   PubMed Web of Science ®Google Scholar
• Lancsar E, Louviere J. Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. PharmacoEconomics. 2008;26(8):661–677. doi:10.2165/00019053-200826080-00004
   PubMed Web of Science ®Google Scholar
• Say RE. The importance of patient preferences in treatment decisions--challenges for doctors. BMJ. 2003;327(1):542–545. doi:10.1136/bmj.327.7414.542
   PubMedGoogle Scholar
• Ng-Mak D, Poon J, Roberts L, Kleinman L, Revicki D, Rajagopalan K. Patient preferences for important attributes of bipolar depression treatments: a discrete choice Experiment. Patient Preference Adherence. 2018;12:35–44. doi:10.2147/PPA.S151561
   PubMed Web of Science ®Google Scholar
• Fairchild AO. Patient preferences for ketamine-based antidepressant treatments in treatment-resistant depression: results from a clinical trial and panel. Neurol Psychiatry Brain Res. 2020;37:67–78. doi:10.1016/j.npbr.2020.05.003
   Google Scholar
• Fifer S, Puig A, Sequeira V, et al. Understanding Treatment Preferences of Australian Patients Living with Treatment-Resistant Depression. Patient Preference Adherence. 2021;15:1621–1637. doi:10.2147/PPA.S311699
   PubMed Web of Science ®Google Scholar
• Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet Oncol. 2007;8(5):370. doi:10.1016/S1470-2045(07)70114-6
   PubMedGoogle Scholar
• Beckman L, von Kobyletzki L, Svensson M. Economic costs of antidepressant use: a population-based study in Sweden. j Mental Health Policy Economics. 2019;22(4):125–130.
   PubMed Web of Science ®Google Scholar
• Patel V, Weiss H, Chowdhary N, et al. Effectiveness of an intervention led by lay health counsellors for depressive and anxiety disorders in primary care in Goa, India (MANAS): a cluster randomised controlled trial. Lancet Oncol. 2010;376(9758):2086–2095. doi:10.1016/S0140-6736(10)61508-5
   Google Scholar
• Cartwright C, Gibson K, Read J, Cowan O, Dehar T. Long-term antidepressant use: patient perspectives of benefits and adverse effects. Patient Preference Adherence. 2016;10:1401–1407. doi:10.2147/PPA.S110632
   PubMed Web of Science ®Google Scholar
• Wiles N, Taylor A, Turner N, et al. Management of treatment-resistant depression in primary care: a mixed-methods study. Br J Gen Pract. 2018;68(675):e673–e681. doi:10.3399/bjgp18X699053
   PubMed Web of Science ®Google Scholar
• Desplenter F, Laekeman G, Simoens S. Differentiated information on antidepressants at hospital discharge: a hypothesis-generating study. Int j Pharmacy Practice. 2013;21(4):252–262. doi:10.1111/ijpp.12001
   PubMedGoogle Scholar
• Interian A, Lewis-Fernández R, Gara M, Escobar J. A randomized-controlled trial of an intervention to improve antidepressant adherence among Latinos with depression. Depression Anxiety. 2013;30(7):688–696. doi:10.1002/da.22052
   PubMed Web of Science ®Google Scholar
• Al-Saffar N, Abdulkareem A, Abdulhakeem A, Salah A, Heba M. Depressed patients’ preferences for education about medications by pharmacists in Kuwait. Patient Educ Counseling. 2008;72(1):94–101. doi:10.1016/j.pec.2008.01.027
   PubMed Web of Science ®Google Scholar
• Klang S, Ben-Amnon Y, Cohen Y, Barak Y. Community pharmacists’ support improves antidepressant adherence in the community. Int Clin Psychopharmacol. 2015;30(6):316–319. doi:10.1097/YIC.0000000000000090
   PubMed Web of Science ®Google Scholar
• Richards D, Bower P, Chew-Graham C, et al. Clinical effectiveness and cost-effectiveness of collaborative care for depression in UK primary care (CADET): a cluster randomised controlled trial. Health Technol Assess. 2016;20(14):1–192. doi:10.3310/hta20140
   Web of Science ®Google Scholar
• Aljumah K, Hassali M. Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study. BMC Psychiatry. 2015;15(1):219. doi:10.1186/s12888-015-0605-8
   PubMedGoogle Scholar
• Meglic M, Furlan M, Kuzmanic M, et al. Feasibility of an eHealth service to support collaborative depression care: results of a pilot study. J Med Int Res. 2010;12(5):e63. doi:10.2196/jmir.1510
   Google Scholar
• Vannachavee U, Seeherunwong A, Yuttatri P, Chulakadabba S. The Effect of a Drug Adherence Enhancement Program on the Drug Adherence Behaviors of Patients With Major Depressive Disorder in Thailand: a Randomized Clinical Trial. Arch Psychiatric Nursing. 2016;30(3):322–328. doi:10.1016/j.apnu.2015.12.001
   PubMed Web of Science ®Google Scholar
• Wiles N, Thomas L, Turner N, et al. Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: follow-up of the CoBalT randomised controlled trial. Lancet Psychiatry. 2016;3(2):137–144. doi:10.1016/S2215-0366(15)00495-2
   PubMed Web of Science ®Google Scholar
• Yusuf H, Magaji MG, Maiha BB, Yakubu SI, Haruna WC, Mohammed S. Impact of pharmacist intervention on antidepressant medication adherence and disease severity in patients with major depressive disorder in fragile north-east Nigeria. J Pharm Heal Serv Res. 2021;12(3):410–416. doi:10.1093/jphsr/rmab030
   Web of Science ®Google Scholar
• Marasine NR, Sankhi S, Lamichhane R. Impact of pharmacist intervention on medication adherence and patient-reported outcomes among depressed patients in a private psychiatric hospital of Nepal: a randomised controlled trial. Hosp Pharm. 2020;57(1):26–31. doi:10.1177/0018578720970465
   PubMed Web of Science ®Google Scholar
• Capoccia K, Boudreau D, Blough D, et al. Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care. Am J Health Syst Pharm. 2004;61(4):364–372. doi:10.1093/ajhp/61.4.364
   PubMed Web of Science ®Google Scholar
• Burton W, Chen C, Conti D, Schultz A, Edington D. The association of antidepressant medication adherence with employee disability absences. Am J Manag Care. 2007;13(2):105–112.
   PubMed Web of Science ®Google Scholar
• Shi J, Chen Y, Jiang Y, et al. Stigma and its associations with medication adherence in major depressive disorder. Psychiatry Res. 2024;331:115664. doi:10.1016/j.psychres.2023.115664
   PubMed Web of Science ®Google Scholar
• Ho S, Jacob S, Tangiisuran B. Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: a qualitative study. PLoS One. 2017;12(6):e0179290. doi:10.1371/journal.pone.0179290
   PubMed Web of Science ®Google Scholar
• Semahegn A, Torpey K, Manu A, Assefa N, Tesfaye G, Ankomah A. Psychotropic medication non-adherence and associated factors among adult patients with major psychiatric disorders: a protocol for a systematic review. Syst Rev. 2018;7(1):10. doi:10.1186/s13643-018-0676-y
   PubMed Web of Science ®Google Scholar
• Zhu Y, Wu Z, Sie O, et al. Causes of drug discontinuation in patients with major depressive disorder in China. Prog Neuropsychopharmacol Biol Psychiatry. 2020;96:109755. doi:10.1016/j.pnpbp.2019.109755
   PubMed Web of Science ®Google Scholar
• DeShazo JR, Fermo G. Designing Choice Sets for Stated Preference Methods: the Effects of Complexity on Choice Consistency. J Environ Econ Manage. 2002;44(1):123–143. doi:10.1006/jeem.2001.1199
   Web of Science ®Google Scholar
• Qiu-chen W, Xiu-ying Z, Hui X, Hua Y, Yi P. Research progress in developing attributes and levels of discrete choice experiments. Mod Preventive Med. 2020;47(12):2199–2201+2210.
   Google Scholar
• de Bekker-Grob E, Hol L, Donkers B, et al. Labeled versus unlabeled discrete choice experiments in health economics: an application to colorectal cancer screening. Value Health. 2010;13(2):315–323. doi:10.1111/j.1524-4733.2009.00670.x
   PubMed Web of Science ®Google Scholar
• Fields BE, Bell JF, Bigbee JL, Holly T, Joanne S. Registered Nurses’ Preferences for Rural and Urban Jobs: a Discrete Choice Experiment. Int j Nursing Studies. 2018;86:11. doi:10.1016/j.ijnurstu.2018.05.012
   PubMed Web of Science ®Google Scholar
• Burgess L, Street DJ. The optimal size of choice sets in choice experiments. Statistics. 2006;40(1):507–515. doi:10.1080/02331880601013841
   Google Scholar
• Reed Johnson FP, Lancsar EP, Marshall DP, et al. Constructing Experimental Designs for Discrete-Choice Experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health. 2013;16(1):3–13. doi:10.1016/j.jval.2012.08.2223
   PubMed Web of Science ®Google Scholar
• Veldwijk J, Lambooij M, de Bekker-Grob E, Smit H, de Wit G. The effect of including an opt-out option in discrete choice experiments. PLoS One. 2014;9(11):e111805. doi:10.1371/journal.pone.0111805
   PubMed Web of Science ®Google Scholar
• Li H, Xue H, Yuan H, Wan G, Zhang X. Preferences of first-degree relatives of gastric cancer patients for gastric cancer screening: a discrete choice experiment. BMC Cancer. 2021;21(1):959. doi:10.1186/s12885-021-08677-9
   PubMed Web of Science ®Google Scholar
• Li H, Han J, Yuan H, Wan G, Xue H, Zhang X. Eliciting gastric cancer survivors’ preferences for follow-up services: a discrete choice experiment protocol. BMJ open. 2021;11(11):e049742. doi:10.1136/bmjopen-2021-049742
   PubMed Web of Science ®Google Scholar
• Bessen T, Chen G, Street J, et al. What sort of follow-up services would Australian breast cancer survivors prefer if we could no longer offer long-term specialist-based care? A discrete choice experiment. Br. J. Cancer. 2014;110(4):859–867.
   PubMed Web of Science ®Google Scholar
• JA W. R W, X G. PLoS One. 2014;9(1):e90635.
   PubMedGoogle Scholar
• Lagarde M, Blaauw D. A review of the application and contribution of discrete choice experiments to inform human resources policy interventions. Human Resources for Health. 2009;7(1):62. doi:10.1186/1478-4491-7-62
   PubMedGoogle Scholar
• Hensher DA, Swait JD, Adamowicz W, Louviere JJ. Stated Choice Methods: Analysis and Applications. Cambridge University Press; 2014.
   Google Scholar
• R. J, B O. Getting the Most from CBC. Sequim: Sawtooth Research Paper Series, Sawtooth Software; 2003.
   Google Scholar
• Orne B. Sample size issues for conjoint analysis. Getting Started with Conjoint Analysis: strategies for Product Design and Pricing Research. Int J Res. 2010:57–66.
   Google Scholar
• Orme B. Getting Started with Conjoint Analysis: Strategies for Product Design and Pricing Research. Second ed. Bibliovault OAI Repository, the University of Chicago Press; 2010.
   Google Scholar
• Ye F, Lord D. Comparing three commonly used crash severity models on sample size requirements: multinomial logit, ordered probit and mixed logit models. Anal Methods Accid Res. 2014;1:72–85. doi:10.1016/j.amar.2013.03.001
   Google Scholar
• Hensher DA, Rose JM, Greene WH. Applied choice analysis: A primer. 2005.
   Google Scholar
• Wang C, Wang D, Zhu W, Song S. Research progress of discrete choice model. Progress Geography. 2015;34:10.
   Google Scholar
• Melfi C, Chawla A, Croghan T, Hanna M, Kennedy S, Sredl K. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry. 1998;55(12):1128–1132. doi:10.1001/archpsyc.55.12.1128
   PubMed Web of Science ®Google Scholar
• Johnson FR. ??zdemir S, Manjunath R, Hauber AB, Burch SP, Thompson TR. Factors Affect Adherence Bipolar Disorder Treatments Medical Care. 2007;45(6):545–552.
   Google Scholar
• Zimmermann TM, Clouth J, Elosge M, et al. Patient preferences for outcomes of depression treatment in Germany: a choice-based conjoint analysis study. Affect Disord. 2013;148(2–3):210–219. doi:10.1016/j.jad.2012.11.062
   PubMed Web of Science ®Google Scholar
• Lagarde M. Investigating attribute non-attendance and its consequences in choice experiments with latent class models. Health Economics Review. 2013;22(5):554–567. doi:10.1002/hec.2824
   Google Scholar
• Hiligsmann M, van Durme C, Geusens P, et al. Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis. Patient Preference Adherence. 2013;7:133–139. doi:10.2147/PPA.S38408
   PubMed Web of Science ®Google Scholar
• Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making: a user’s guide. PharmacoEconomics. 2008;26(8):661–677.
   PubMed Web of Science ®Google Scholar
• Bridges JFPP, Hauber ABP, Marshall DP, et al. Conjoint Analysis Applications in Health—a Checklist: a Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14(4):403–413. doi:10.1016/j.jval.2010.11.013
   PubMed Web of Science ®Google Scholar
• Mangham LJ, Kara H, Barbara MP. How to do (or not to do) … Designing a discrete choice experiment for application in a low-income country. Health Policy Plan. 2009;24(2):151–158. doi:10.1093/heapol/czn047
   PubMed Web of Science ®Google Scholar